Overview
Poliomyelitis (commonly known as polio) is an acute infectious disease caused by the poliovirus, a human enterovirus belonging to the Picornaviridae family. The virus is transmitted primarily through the fecal-oral route and initially replicates in the oropharynx and gastrointestinal tract before potentially invading the central nervous system. While the majority of poliovirus infections are asymptomatic or cause only mild flu-like illness, in a small percentage of cases the virus destroys motor neurons in the spinal cord and brainstem, leading to acute flaccid paralysis. The disease predominantly affects the lower extremities, though any voluntary muscle group can be involved, including respiratory muscles, which can be life-threatening. Key clinical features of paralytic poliomyelitis include asymmetric acute flaccid paralysis, muscle weakness, loss of reflexes, and muscle atrophy. The disease can present in several forms: spinal poliomyelitis (affecting limb muscles), bulbar poliomyelitis (affecting cranial nerves and respiratory centers), or bulbospinal poliomyelitis (a combination of both). Initial symptoms often include fever, fatigue, headache, neck stiffness, and limb pain, followed by rapid onset of weakness. Decades after the acute infection, some survivors develop post-polio syndrome, characterized by new progressive muscle weakness, fatigue, and pain. There is no specific antiviral treatment for poliomyelitis. Management is supportive and includes physical therapy, orthopedic interventions, respiratory support when needed, and rehabilitation to maximize functional recovery. Prevention through vaccination remains the cornerstone of disease control. Two highly effective vaccines exist: the inactivated poliovirus vaccine (IPV, Salk vaccine) and the oral poliovirus vaccine (OPV, Sabin vaccine). Global vaccination campaigns led by the Global Polio Eradication Initiative have reduced wild poliovirus cases by over 99% since 1988, though the disease has not yet been fully eradicated worldwide.
Clinical phenotype terms— hover any for plain English:
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsChina National Biotec Group Company Limited
Fidec Corporation — PHASE3
Sinovac Biotech Co., Ltd — PHASE4
PATH — PHASE2
Sinovac Biotech Co., Ltd — PHASE4
International Centre for Diarrhoeal Disease Research, Bangladesh — PHASE4
CanSino Biologics Inc. — PHASE1, PHASE2
PATH — PHASE1, PHASE2
Institute of Medical Biology, Chinese Academy of Medical Sciences — PHASE4
Serum Institute of India Pvt. Ltd. — PHASE3
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Poliomyelitis.
8 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Poliomyelitis.
Community
No community posts yet. Be the first to share your experience with Poliomyelitis.
Start the conversation →Latest news about Poliomyelitis
Disease timeline:
New recruiting trial: Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
A new clinical trial is recruiting patients for Poliomyelitis
New recruiting trial: Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
A new clinical trial is recruiting patients for Poliomyelitis
New recruiting trial: Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
A new clinical trial is recruiting patients for Poliomyelitis
New recruiting trial: A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
A new clinical trial is recruiting patients for Poliomyelitis
New recruiting trial: Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
A new clinical trial is recruiting patients for Poliomyelitis
New recruiting trial: Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
A new clinical trial is recruiting patients for Poliomyelitis
New recruiting trial: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
A new clinical trial is recruiting patients for Poliomyelitis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Poliomyelitis
What is Poliomyelitis?
Poliomyelitis (commonly known as polio) is an acute infectious disease caused by the poliovirus, a human enterovirus belonging to the Picornaviridae family. The virus is transmitted primarily through the fecal-oral route and initially replicates in the oropharynx and gastrointestinal tract before potentially invading the central nervous system. While the majority of poliovirus infections are asymptomatic or cause only mild flu-like illness, in a small percentage of cases the virus destroys motor neurons in the spinal cord and brainstem, leading to acute flaccid paralysis. The disease predomina
Are there clinical trials for Poliomyelitis?
Yes — 8 recruiting clinical trials are currently listed for Poliomyelitis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Poliomyelitis?
25 specialists and care centers treating Poliomyelitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.